Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has provided an update.
Recce Pharmaceuticals Ltd. has announced a change in the substantial holding of its shares, with Gavin William Brown increasing his voting power from 7.16% to 12.39% through the acquisition of shortfall shares from the company’s recent entitlement offer. This change in shareholding could potentially impact the company’s governance and strategic decisions, reflecting increased investor confidence in Recce Pharmaceuticals’ market positioning and future prospects.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of new antibiotics to address serious and life-threatening infections. The company is known for its innovative approach to combating antibiotic-resistant bacteria, which is a significant concern in the healthcare sector.
Average Trading Volume: 221,214
Technical Sentiment Signal: Sell
Current Market Cap: A$79.91M
For detailed information about RCE stock, go to TipRanks’ Stock Analysis page.